Role of surfacelet transform in diagnosing Alzheimer’s disease
- 18 Downloads
The clinical diagnosis of Alzheimer’s disease (AD) is based on the tedious questionnaire and prolonged tests, which require involvement of the patient, his/her family, and the clinician. Ultimately, the success of subjective evaluation depends on the expertise of the clinician. To eradicate this subjectivity, the present work proposes a method to automate the diagnosis of AD. The proposed method represents complex brain structure of the subject (captured by MRI, a safe and non-invasive medical imaging modality) in terms of quantifiable features and then performs classification of normal and AD subjects. It does so in three phases: (1) MRI volume is normalized and the gray matter, which is the most affected tissue in AD is extracted from the regions of interest. (2) Surfacelet transform, a 3D multi-resolution transform that captures intricate directional details, is applied on the volume to extract features. The features are then reduced by selecting relevant and non-redundant features using a combination of Fisher discriminant ratio, and minimum redundancy and maximum relevance feature selection methods. (3) Based on these features, AD patients and normal subjects are classified using support vector machine classifier with 10 runs of 10 fold cross-validation. The performance of the method was computed using three measures (sensitivity, specificity, classification accuracy) on three datasets, constructed from the publically available database. It achieved 78.04%, 98.00% and 84.37% classification accuracies on the three datasets respectively. The effectiveness of the proposed method is validated by comparing it with other existing methods under identical experimental settings using the above three performance measures as well as receiver operating characteristic curves, ranking and statistical tests. Overall, it significantly outperformed the existing methods. It indicates that the proposed method has the potential to assist clinicians in the decision making for the diagnosis of AD.
KeywordsAlzheimer’s disease Classification Feature selection Minimum redundancy maximum relevance (mRMR) Structural magnetic resonance imaging (MRI) Surfacelet transform
We thank Dr. S. Senthil Kumaran, All India Institute of Medical Sciences for his valuable inputs in the early phases of this work. We extend our gratitude to the Department of Science and Technology, the Government of India for providing financial support in this research work.
- A. A. Martinos Center for Biomedical Imaging. (2017). Freesurfer. Massachusetts General Hospital. [Online]. Retrieved May 2017 from http://surfer.nmr.mgh.harvard.edu/.
- Aggarwal, N., Rana, B., & Agrawal, R. K. (2014). Statistical features-based diagnosis of Alzheimer’s disease using MRI. In M. Sarfraz (Ed.), Computer vision and image processing in intelligent systems and multimedia technologies (pp. 38–53). IGI Global.Google Scholar
- Beheshti, I., Demirel, H., Matsuda, H., & Initiative, A. D. N. (2017). Classification of Alzheimer’s disease and prediction of mild cognitive impairment-to-Alzheimer’s conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm. Computers in Biology and Medicine, 83, 109–119.CrossRefGoogle Scholar
- Bouckaert, R. R., & Frank, E. (2004). Evaluating the replicability of significance tests for comparing learning algorithms. In Pacific-Asia conference on knowledge discovery and data mining (PAKDD), Sydney, Australia.Google Scholar
- Duin, R., Juszcak, P., Paclik, P., Pekalska, E., De Ridder, D., & Tax, D. (2004). PrTools: The Matlab toolbox for pattern recognition. Delft University of Technology. [Online]. Retrieved January 2004, from http://www.prtools.org.
- Marcus, D. S., Wang, T. H., Parker, J., Csernansky, J. G., Morris, J. C., & Buckner, R. L. (2007). Open access series of imaging studies (OASIS): Cross-sectional MRI data in young, middle aged, nondemented, and demented older adults. Journal of Cognitive Neuroscience, 19(9), 1498–14507.CrossRefGoogle Scholar
- US National Institute on Aging. (2005). Progress report on Alzheimer’s disease 2004–2005. National Institutes of Health (NIH): Bethesda.Google Scholar
- Wellcome-Trust-Centre-for-Neuroimaging. (2009). SPM8—Statistical parametric mapping. University College London. [Online]. Retrieved April 2009, from http://www.fil.ion.ucl.ac.uk/spm/software/spm8/.